Ensysce Biosciences (ENSC) Total Non-Current Liabilities (2018 - 2025)
Ensysce Biosciences (ENSC) recorded Total Non-Current Liabilities of $35.00 in Q3 2025, down 98.9% from $3,213 a year earlier and down 96.6% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
At the end of FY2024, Ensysce Biosciences reported Total Non-Current Liabilities of $10,096, down 61.7% from FY2023.
- Annual Total Non-Current Liabilities has declined for three straight years, with a five-year compound annual growth rate of -86.1% (FY2019 to FY2024).
- Across earlier years, Total Non-Current Liabilities came in at $26,388 in FY2023 (-94.1%), $450,494 in FY2022 (-94.4%), $8.09 million in FY2021 (+978.8%) and $750,234 in FY2020 (-99.6%).
- The Q3 2025 figure is the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2018.
- On a year-over-year basis, Total Non-Current Liabilities rose in 1 of the last eight quarters, with growth averaging 6.6%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 978.8% in Q4 2021, against a decline of 99.6% in Q4 2020 at the low end.
- Per Business Quant, the preceding three quarters came in at $1,033 (Q2 2025), $130,180 (Q1 2025) and $10,096 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Ensysce Biosciences | 1.35 Mn | -9.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 35.00 |
| Jun 30, 2025 | 1,033.00 |
| Mar 31, 2025 | 130,180.00 |
| Dec 31, 2024 | 10,096.00 |
| Sep 30, 2024 | 3,213.00 |
| Jun 30, 2024 | 9,615.00 |
| Mar 31, 2024 | 17,433.00 |
| Dec 31, 2023 | 26,388.00 |
| Sep 30, 2023 | 30,473.00 |
| Jun 30, 2023 | 47,696.00 |
| Mar 31, 2023 | 91,318.00 |
| Dec 31, 2022 | 450,494.00 |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 8.39 Mn |
| Mar 31, 2022 | 2.46 Mn |
| Dec 31, 2021 | 8.09 Mn |
| Sep 30, 2021 | 3.07 Mn |
| Mar 31, 2021 | 11.98 Mn |
| Dec 31, 2020 | 750,234.00 |
| Dec 31, 2019 | 196.02 Mn |
API Access
Ensysce Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();